help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on February 22, 2007
Endocrinology, doi:10.1210/en.2006-1221
A more recent version of this article appeared on May 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
148/5/2168    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, L.
Right arrow Articles by Wang, H.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, L.
Right arrow Articles by Wang, H.-Y.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH

Submitted on September 6, 2006
Accepted on February 8, 2007

Negative Regulation of c-Myc Transcription by Pancreas Duodenum Homeobox-1

Lei Chen, He-Xin Yan, Jing Chen, Wen Yang, Qiong Liu, Bo Zhai, Hui-Fang Cao, Shu-Qin Liu, Meng-Chao Wu, and Hong-Yang Wang*

International Co-operation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, SMMU, 200438 Shanghai; State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Science, Fudan University, 200433 Shanghai; Department of Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, 200438, Shanghai, P.R.China

* To whom correspondence should be addressed. E-mail: hywangk{at}vip.sina.com.

The pancreatic and duodenal homeobox factor-1 (Pdx1) is essential for pancreatic development and insulin gene transcription whereas c-Myc has a deleterious effect on islet function. However, the relationship between c-Myc and Pdx1 is poorly concerned. Here we demonstrated that Pdx1 could suppress c-Myc promoter activity, which relied on Tcf binding elements harbored in c-Myc promoter. Furthermore, the transcription activity of {beta}-catenin/Tcf was markedly decreased upon Pdx1 expression, but cotransfection of Pdx1 shRNA abrogated this effect. Pdx1 expression did not induce {beta}-catenin degradation nor did it alter their subcellular distribution. The mutation analysis showed that the amino acids (1-209) of Pdx1 harboring an inhibitory domain, which might lead to the reduction of {beta}-catenin/Tcf/p300 complex levels and attenuate their binding activity with c-Myc promoter sequences. Moreover, Adenovirus-mediated Pdx1 interference caused cell proliferation and cytokine-induced apoptosis via the dysregulation of c-Myc transcription. These results indicated that the Pdx1 functioned as a key regulator for maintenance of {beta} cells function, at least in part, through controlling c-Myc expression and the loss of its regulatory function may be an alternative mechanism for {beta}-cell neogenesis and apoptosis found in diabetes.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society